Jordan Marcou, PA
Physician Assistant · Trumbull, CTNPI 1154834786
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $36,657 of the $44,235 with a category attached, or 82.9%. It is spread thinly across 38 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,760 payments — averaging $25.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Idorsia Pharmaceuticals US Inc$8K
- AbbVie$4K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$4K
- Otsuka America Pharmaceutical, Inc.$4K
- Takeda Pharmaceuticals U.S.A., Inc.$3K
- Lundbeck LLC$3K
- plus $18K from 32 others
What the payments were for
- Consulting fees$7202%
- Speaking & faculty fees$4,79311%
- Travel & lodging$1,7094%
- Food & beverage$36,65783%
- Education$3571%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$44,235 in reported general payments places this provider in the 95th percentile of 1,795 physician assistant providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 34 | $49,873 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 218 | $39,392 |
| TrintellixVortioxetine Hydrobromide | 34 | $35,535 |
| VraylarCariprazine Hcl | 12 | $27,865 |
| BelsomraSuvorexant | 46 | $20,945 |
| SecuadoAsenapine | 12 | $19,441 |
| QuviviqDaridorexant Hcl | 22 | $10,924 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 15 | $7,359 |
| VyvanseLisdexamfetamine Dimesylate | 16 | $6,232 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 117 | $4,205 |
| Aripiprazole | 39 | $3,398 |
| Alprazolam | 294 | $3,151 |
| Clonazepam | 273 | $2,685 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 40 | $2,617 |
| Buprenorphine Hcl | 45 | $2,399 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $3,607 | $49,87334 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse | $3,206 | $41,76750 claims |
| AbbVieVraylar | $4,353 | $27,86512 claims |
| MerckBelsomra | $341 | $20,94546 claims |
| Idorsia Pharmaceuticals US IncQuviviq | $7,832 | $10,92422 claims |
| Indivior Inc.Suboxone | $802 | $7,35915 claims |
| Almatica Pharma LLCSertraline Hcl | $405 | $73795 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,795 physician assistant providers in Connecticut.
Other physician assistant in Trumbull
- Gary SpinnerBridgeport$119K
- Mary ElliottGuilford$43K
- Christopher ThompsonGroton$42K
- Michael LalondeNew Haven$35K
- Kristine LaneMiddletown$30K
- Kathryn MidgleyNew Haven$28K
- Richard MoroPlainfield$25K
- Janine TedescoDarien$21K
- Marina MathewFairfield$20K
- William WrayMystic$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.